YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FZX65
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,671
Award facts
- Contract value 100% obligated
- $55,671.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,671.00 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed price structure with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
The award reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering vaccines, medications, biologics, and medical consumables distributed to Department of Defense healthcare sites nationally. The company's consistent success in competing for DLA pharmaceutical contracts without set-aside designations, combined with its woman-owned small business status, demonstrates its competitive positioning in federal procurement markets. YF-VAX, a yellow fever vaccine, represents the type of specialized pharmaceutical product integral to supporting the medical supply needs of military health facilities across the Defense Logistics Agency's distribution network.
Quick answers
Who was awarded contract SPE2DB25FZX65?
SPE2DB25FZX65 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FZX65 worth?
The government has obligated $55,671 on SPE2DB25FZX65.
Is contract SPE2DB25FZX65 an order under another contract?
Yes. SPE2DB25FZX65 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX65 competed?
The extent of competition for SPE2DB25FZX65 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award